Inhaled kanamycin in the treatment of multidrug-resistant tuberculosis: A study of five patients

Infectious Diseases in Clinical Practice

Volumn 7, Issue 1, 1998, Pages 49-53

  Turner, Marie T ^b   Haskal, Ruth ^b   McGowan, Katherine ^a   Nardell, Edward ^b   Sabbag, Russell ^b  

^a Brigham and Women's/Faulkner Hospitals   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; KANAMYCIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG TUBERCULOSIS; MALE; MULTIDRUG RESISTANCE; STUDY;

EID: 0031909217     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199801000-00010     Document Type: Article

References (6)

1. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh R. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993;328:527-32.
2. Iseman MD, Madsen L, Iseman M, Ackerson L. Impact of surgery on the management of MDR-TB [abstract]. Am J Respir Crit Care Med 1995;151(4. Part 2):A336.
3. Telzak EE, Sepkowitz K, Alpert P, et al. Multidrug-resistant tuberculosis in patients without HIV infection. N Engl J Med 1995;333:907-11.
4. Pennington J. Penetration of antibiotics into respiratory secretions. Rev Infect Dis 1981;3:67-73.
5. Faurisson F, Brun-Pascaud M. Une autre voie d'administration des aminosides: les aerosols. J Pharmacol Clin 1988;2:53-62. See [6].
6. Le Conte P, Potel G, Peltier P, et al. Lung distribution and pharmacokinetics of aerosolized tobramycin. Am Rev Respir Dis 1993;147:1279-82.